BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoodLifeSci - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GoodLifeSci
X-ORIGINAL-URL:https://goodlifesci.sidley.com
X-WR-CALDESC:Events for GoodLifeSci
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Singapore
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:+08
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20221201T170000
DTEND;TZID=Europe/Zurich:20221201T200000
DTSTAMP:20260403T123425
CREATED:20221005T175157Z
LAST-MODIFIED:20221103T173736Z
UID:1277-1669914000-1669924800@goodlifesci.sidley.com
SUMMARY:Women’s Life Sciences Network Event – Zürich
DESCRIPTION:Digital Health and Artificial Intelligence: Drivers in Transforming the Life Sciences Industry \nJoin us in Zürich for our next Women’s Life Sciences Network event\, which will feature a panel discussion with leading life sciences industry women about the use of artificial intelligence and digital health. \n \nModerated panel discussion: \n\nData augmenting in healthcare\n\n\nChallenges and opportunities in digital health\n\n\nArtificial intelligence in drug development and beyond\n\nSPEAKERS \nFleur Herrenschmidt\nHead Legal Region Europe Pharma\nNovartis \nLisa Kinsella\nVice President and General Counsel\nModerna \nAfua van Haasteren\nManager\, Health Policy and External Affairs\nRoche Diagnostics \nRSVP HERE \n5:00 – 8:00 p.m. CET\nThe panel discussion will be followed by a networking reception and walking dinner. \nFor more information\, please contact Cristina Menendez Ruiz at +32 2 504 6453 or at cmenendezruiz@sidley.com. \nClick here to join the Women’s Life Sciences Network LinkedIn Group. \nJosefine Sommer\nSenior Managing Associate\, Sidley Austin LLP\nWLSN Co-Founder\njosefine.sommer@sidley.com \nTatjana Sachse\nCounsel\, Sidley Austin LLP\nWLSN Lead\ntsachse@sidley.com \nAnna Pavlou\nHead of Legal\, Global R&D and Regulatory at Galderma\nWLSN Co-Founder\nAnna.Pavlou@galderma.com \n\nIn light of the COVID-19 pandemic\, Sidley is taking precautions to safeguard the well-being of our clients\, colleagues\, and guests. We encourage you to practice social distancing and follow local guidelines. If you are experiencing cold- or flu-like symptoms or if you have been in contact with anyone who has been exposed to or infected with COVID-19 within the past 14 days\, please refrain from attending this event. We appreciate your cooperation and concern for the health and safety of our guests.
URL:https://goodlifesci.sidley.com/event/womens-life-sciences-network-event-zurich/
LOCATION:Kraftwerk\, Selnaustrasse 25\, Zürich\, 8001\, Switzerland
ATTACH;FMTTYPE=image/png:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/10/MN-11337-WLSN-Sidley-865px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230510T140000
DTEND;TZID=America/New_York:20230510T160000
DTSTAMP:20260403T123425
CREATED:20230404T173638Z
LAST-MODIFIED:20230508T211204Z
UID:1521-1683727200-1683734400@goodlifesci.sidley.com
SUMMARY:Sidley Digital Health East
DESCRIPTION:Please join us on Wednesday\, May 10 for a digital health-focused roundtable hosted by Sidley and The Digital Therapeutics Alliance. Across two panels\, we will discuss important and timely topics including marketing pathways\, coverage and reimbursement issues\, and more. Get industry tips and key watchouts from a look at the current marketplace. \n \nWhat Does Success Look Like? Overcoming FDA Hurdles and Obtaining Reimbursement\nPanelists will discuss how to successfully bring digital health to market by considering both FDA and post-approval coverage and reimbursement challenges and paths forward. Listen for an update on FDA’s latest guidance and how to make it work for you\, as well as how to navigate benefit categories and reimbursement decisions across payors. \n\nAnnie Saha\, Assistant Director\, Digital Health Center of Excellence\, FDA\nAndy Molnar\, CEO\, Digital Therapeutics Alliance (DTA)\nDeitzah Raby\, General Counsel\, AppliedVR\nEverett Crosland\, Chief Commercial Officer\, Cognito Therapeutics\n\nFireside Chat with Seth Feuerstein\, Founder and CEO of Oui Therapeutics\, and Melissa Reilly\, Chief Growth Officer at Evernorth Behavioral Health\nHear from two experts deeply engaged in digital health. We will hear them share their stories\, discuss launching new digital health therapies\, and speak to expertise that brought them to where they are today. \n\nSeth Feuerstein\, MD\, JD\, Founder and CEO\, Oui Therapeutics and Executive Director and Founder\, Center for Digital Health\, Innovation and Excellence\, Yale School of Medicine\nMelissa Reilly\, Chief Growth Officer\, Evernorth Behavioral Health\n\nFor more information or questions\, please contact globallifesci@sidley.com. \nBoston Life Sciences Roundtable:\nLooking for a deep dive on the current life sciences landscape? Join us for an afternoon of discussions addressing cutting-edge trends at the Boston Life Sciences Roundtable\, on Thursday\, May 11\, following Sidley Digital Health East. Click here for more information and registration. \nThe health of our clients\, colleagues\, and guests is important to us. If you are experiencing cold or flu-like symptoms please stay home and get better. If you are recovering from COVID-19 or have been recently exposed\, please follow applicable guidelines.
URL:https://goodlifesci.sidley.com/event/sidley-digital-health-east/
LOCATION:700 Technology Square\, Cambrige\, MA 02139
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230511
DTEND;VALUE=DATE:20230512
DTSTAMP:20260403T123425
CREATED:20230404T175257Z
LAST-MODIFIED:20241118T220253Z
UID:1527-1683763200-1683849599@goodlifesci.sidley.com
SUMMARY:Boston Life Sciences Roundtable
DESCRIPTION:Please join Sidley for the Boston Life Sciences Roundtable\, an afternoon of provocative discussions addressing cutting-edge trends and hot topics. \n \n \nFEATURED PANELS \n Please see below for discussion topics during the Boston Life Sciences Roundtable: \nLeading Life Sciences Companies: A Conversation with Boston Area Life Sciences General Counsel\n \n\nTy Howton\, Chief Administrative Officer and Secretary\, Solid Biosciences Inc.\nJoan Schmidt\, Chief Legal Officer\, Pharvaris\nAsher Rubin\, Partner\, Co-leader\, Technology and Life Sciences Transactions\nBecky Wood\, Partner\, Co-leader\, Food\, Drug and Medical Device and former FDA Chief Counsel\n\nCharting New Courses: Key Healthcare and FDA Developments for Life Sciences Companies\n \n\nJoe Philipose\, Chief Ethics and Compliance Officer\, Emergent BioSolutions\nLynn Zuchowski\, Vice President\, Chief Counsel\, Severe Genetic Diseases\, bluebird bio\, Inc.\nMeena Datta\, Partner\, Co-leader\, Healthcare\nScott Kaplan\, Partner\, Food\, Drug and Medical Device\n\nProspecting in Uncertain Times: New Approaches to Funding the Next Blockbuster\n \n\nSusan Graf\, Senior Advisor & Entrepreneur In Residence\, Locust Walk; Board Chair\, Finch Therapeutics; Audit Committee Chair\, Kaléo\nMike Mano\, Senior Vice President and General Counsel\, Karyopharm Therapeutics\nGeoff Levin\, Partner\, Private Equity\nAlison Lehner\, Partner\, Emerging Companies and Venture Capital\n\nKeynote Presentation \n\nLeading With Empathy: Understanding Compassion and Emotional Storytelling for Life Sciences Companies\n\nYotam Dagan\nA former Israeli Navy SEALs commander\, certified clinical psychologist\, and hostage negotiator\, Yotam has moved from leading soldiers on the battlefield to building their fighting capacity and caring for their wellbeing. A global resilience expert\, Yotam founded Dugri Inc – a startup that builds real-talk-based\, safe\, vertical communities. His book\, A Time to Kill\, a Time to Heal – An Israeli Navy SEAL’s Journey\, came out in 2021. \nAGENDA \n1:30 p.m. Arrival and Registration\n2:00 p.m. Program\n5:30 p.m. Reception \nJoin us on-site during the reception for a special hands-on service project.
URL:https://goodlifesci.sidley.com/event/boston-life-sciences-roundtable-2/
LOCATION:MassBio Hub\, 700 Technology Square\, Cambridge\, MA 02139
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230523
DTEND;VALUE=DATE:20230524
DTSTAMP:20260403T123425
CREATED:20230215T183630Z
LAST-MODIFIED:20230215T185738Z
UID:1455-1684800000-1684886399@goodlifesci.sidley.com
SUMMARY:The EU’s New Health Technology Assessments Regulation
DESCRIPTION:Join us in Brussels for our next Women’s Life Sciences Network event\, which will feature a special address by Ruta Janeckaite (European Commission). \n \nThe discussion will include: \n\nStatus of the Commission’s preparation and tasks ahead\nRegulatory opportunities\nIndustry implementation path\n\nA Q&A session will follow the moderated discussion. \n6:00 p.m. CET \nThe panel discussion will be followed by networking drinks \nDr. Ruta Janeckaite\, PhD\nLegal Officer\nEuropean Commission \nRuta is a Lithuanian lawyer\, graduate from the Law Faculty of Vilnius University. Since 2003\, she has been working in the field of EU and EEA law: in the European Law Department under the Ministry of Justice of Lithuania from 2003 to 2013\, in the EFTA Surveillance Authority from 2013 to 2020\, and in the European Commission since 2020. Currently\, she is part of DG SANTE health technology assessment team\, responsible for legal issues relating to the implementation and application of Regulation (EU) 2021/2282 on health technology assessment. \nIn January 2022\, Ms. Janeckaite was accorded a doctor’s degree by Vilnius University\, for the dissertation\, “The impact of the EU internal market freedoms and competition rules on the organisation and regulation of the Lithuanian system of health protection.” \nFor more information\, please contact Cristina Menendez Ruiz at +32 2 504 6453 or at cmenendezruiz@sidley.com.\n\nThe health of our clients\, colleagues\, and guests is important to us. If you are experiencing cold or flu-like symptoms please stay home and get better. If you are recovering from COVID-19 or have been recently exposed\, please follow applicable guidelines.
URL:https://goodlifesci.sidley.com/event/the-eus-new-health-technology-assessments-regulation/
LOCATION:Comet\, Place Stephanie 50\, Brussels\, 1050\, Belgium
ATTACH;FMTTYPE=image/png:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/10/MN-11337-WLSN-Sidley-865px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230605
DTEND;VALUE=DATE:20230606
DTSTAMP:20260403T123425
CREATED:20230524T191817Z
LAST-MODIFIED:20230524T191817Z
UID:1601-1685923200-1686009599@goodlifesci.sidley.com
SUMMARY:Sidley Networking Reception at BIO
DESCRIPTION:Please join Sidley for a networking event during BIO 2023. Connect with fellow biotech and pharma colleagues and engage in discussion about industry trends and learnings from BIO. \nRSVP Here\nPlease RSVP by Friday\, May 26. \n \nThe health of our clients\, colleagues\, and guests is important to us. If you are experiencing cold or flu-like symptoms please stay home and get better. If you are recovering from COVID-19 or have been recently exposed\, please follow current CDC guidelines.
URL:https://goodlifesci.sidley.com/event/sidley-networking-reception-at-bio/
LOCATION:Legal Sea Foods – Harborside\, 3rd Floor East Deck 270 Northern Avenue\, A 10 minute walk / 3 minute drive from the Boston Convention and Exhibition Center\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20230628T130000
DTEND;TZID=America/Chicago:20230628T163000
DTSTAMP:20260403T123425
CREATED:20230517T203419Z
LAST-MODIFIED:20230620T212823Z
UID:1573-1687957200-1687969800@goodlifesci.sidley.com
SUMMARY:Bay Area Lifesciences Roundtable
DESCRIPTION:Please join Sidley for the Bay Area Lifesciences Roundtable\, an afternoon of provocative discussions addressing cutting-edge trends and hot topics. \n \nFeatured Panels \nGetting Approved: Creative Approaches to Ensuring Regulatory Success in New Product Development \n\nLisa Taylor Ash\, General Counsel\, Shape Therapeutics\nMaryam Khotani\, Associate General Counsel\, Practice Group Leader\, Genentech\nMichael Listgarten\, General Counsel\, RAPT Therapeutics\nJoel Silver\, JD\, RAC\, Lead Regulatory Counsel at Gilead Sciences\nTorrey Cope\, Partner\, Food\, Drug and Medical Device\, Sidley\n\nGetting Paid: Strategies to address emerging issues in drug pricing and reimbursement at all phases of drug development\, marketing\, and business development activities. \n\nMegan Duplanty\, Vice President\, Deputy General Counsel\, BioMarin Pharmaceutical Inc.\nErin Quirk\, M.D.\, President\, Terns Pharmaceuticals\nRekha Ramesh\, Vice President\, Head of Global Policy\, Government Affairs and Policy\, Gilead Sciences\nMeenakshi Datta\, Partner\, Global Co-leader\, Healthcare\, Sidley\n\nGetting Funded: Prioritizing your pipeline and exploring funding alternatives and strategic opportunities to advance your initiatives. \n\nRekha Hemrajani\, Member\, Board of Directors\, BioAge Labs\nGrace McMahon\, Head of Transactions\, Merck\nFrank Tang\, Executive Director\, Morgan Stanley\nFrank Rahmani\, Partner\, Global Life Sciences and Capital Markets\, Sidley\n\nAgenda \n1:00 p.m. – Registration\n1:30 p.m. – Program\nCocktail reception to follow \nWho Should Attend \nExecutives\, Investors\, General Counsel and Company Counsel \nFor questions\, please contact GlobalLifeSci@sidley.com.
URL:https://goodlifesci.sidley.com/event/bay-area-lifesciences-roundtable/
LOCATION:SFMOMA Outdoor Sculpture Garden\, 147 Minna St.\, Floor 5\, San Francisco\, CA\, 94105\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230912T113000
DTEND;TZID=Europe/London:20230912T183000
DTSTAMP:20260403T123425
CREATED:20230622T142746Z
LAST-MODIFIED:20230622T142851Z
UID:1648-1694518200-1694543400@goodlifesci.sidley.com
SUMMARY:Sidley Healthcare Investment Conference 2023
DESCRIPTION:With deal and investment activity remaining critical for the success of the life sciences and healthcare industry\, Sidley is bringing together senior pharma\, biotech\, healthcare\, private equity\, and venture capital leads to provide their insights on key topics\, trends\, and opportunities. \nRSVP Here \nJoin Sidley and industry leaders from across the globe for this in-person\, one-day event in London\, with the option to stream and network virtually from outside the UK. \nWe look forward to incisive content\, robust discussion\, and valuable networking during a day looking at the continued combination of innovation and capital driving positive patient outcomes and investment returns. \nView confirmed speakers. \nView agenda.\n\nPlease note\, due to space limitation for this event\, registrations will be reviewed and confirmed by email in due course. We strongly encourage in-person attendance and remote participation will be available to those based outside of the UK. \nThe health of our clients\, colleagues\, and guests is important to us. If you are experiencing cold or flu-like symptoms please stay home and get better. If you are recovering from COVID-19 or have been recently exposed\, please follow applicable guidelines. \nFor more information or questions\, please contact lnevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/sidley-healthcare-investment-conference-2023/
LOCATION:The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, UK\, The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240501
DTEND;VALUE=DATE:20240502
DTSTAMP:20260403T123425
CREATED:20240416T162301Z
LAST-MODIFIED:20241118T220313Z
UID:1910-1714521600-1714607999@goodlifesci.sidley.com
SUMMARY:Boston Life Sciences Roundtable
DESCRIPTION:Join Sidley at our annual Boston Life Sciences Roundtable for an afternoon of engaging discussion addressing cutting-edge trends and hot topics. \n \n1:30 p.m. Registration | 2:00 p.m. Program | 5:00 p.m. Reception\nFor more information\, contact bosevents@sidley.com. \nFEATURED PANEL TOPICS\n\nI Used To Practice Law: A Conversation with Life Sciences Leaders\nA rare few life sciences leaders have served in both chief legal and chief business officer roles during the course of their careers.  Join our discussion of making the transition  \n\n\n\nAnna Barry\, Venture Partner\, Deerfield Management\nJerald Korn\, Chief Executive Officer\, Ropirio Therapeutics\, Inc.\nAsher Rubin\, Partner\, Global Co-leader\, Technology and Life Sciences Transactions\nBecky Wood\, Partner\, Global Co-leader\, Food\, Drug and Medical Device and former FDA Chief Counsel\n\n\n\nStrategies for Success: Navigating Current Healthcare and FDA Trends for Life Sciences Companies\nThe session will cover hot topics and regulatory developments from both an FDA and healthcare perspective. \n\n\n\nScott Kaplan\, Deputy General Counsel\, Baxter International Inc.\nPeter Smith\, Head of Legal\, argenx US\, Inc.\nDonielle McCutcheon\, Partner\, Healthcare\nJim Johnson\, Partner\, Food\, Drug and Medical Device\n\n\n\nLife Sciences Transactions: Updates and Perspectives on the Market\nFrom green shoots and increased deal activity to supply chain disruptions and Congressional investigations\, this panel will explore important updates affecting the environment for life sciences transactions. \n\n\n\nAndy Meyerson\, Managing Director\, Locust Walk\n\nJason Russell\, Managing Director\, Global Head of Biotechnology\, Morgan Stanley\nMichael Borden\, Partner\, Leader\, Government Strategies\nAlison Lehner\, Partner\, Emerging Companies and Venture Capital\nAdriana Tibbitts\, Partner\, Technology and Life Sciences Transactions
URL:https://goodlifesci.sidley.com/event/boston-life-sciences-roundtable-3/
LOCATION:MassBio Hub\, 700 Technology Square\, Cambridge\, MA 02139
ATTACH;FMTTYPE=image/jpeg:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/06/MN14393-Boston-Life-Sciences-Event-Banner-865px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240507T080000
DTEND;TZID=America/Chicago:20240507T093000
DTSTAMP:20260403T123425
CREATED:20240321T150358Z
LAST-MODIFIED:20240321T150358Z
UID:1872-1715068800-1715074200@goodlifesci.sidley.com
SUMMARY:ICCA 2024 Hong Kong Sidley Breakfast Seminar
DESCRIPTION:Join us for an engaging and informative panel discussion on life sciences disputes as part of ICCA 2024 Hong Kong. Our panel comprising Sidley disputes and life sciences specialists as well as inhouse counsel will explore (i) general trends in life sciences transactions\, (ii) the complexities and unique challenges involved in life sciences disputes with a focus on IP and cross-border issues\, (iii) strategies on how to avoid and manage potential disputes in life sciences transactions\, and (iv) case studies and practical insights. \nRSVP Here \n \n8:00 a.m. HKT: Registration\n8:30 – 9:30 a.m. HKT: Panel discussion \nOur international panel of specialists will comprise partners from Sidley’s Global Arbitration\, Trade and Advocacy and Global Life Sciences practices\, as well as representatives from the life sciences industry.
URL:https://goodlifesci.sidley.com/event/icca-2024-hong-kong-sidley-breakfast-seminar/
LOCATION:The Clipper\, The American Club\, Floors 48-49\, Two Exchange Square\, Central\, Hong Kong
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240514T130000
DTEND;TZID=America/New_York:20240514T140000
DTSTAMP:20260403T123425
CREATED:20240502T211916Z
LAST-MODIFIED:20240502T212138Z
UID:1923-1715691600-1715695200@goodlifesci.sidley.com
SUMMARY:FDA’s New Wave of Promotion Enforcement: What You Need to Know Now
DESCRIPTION:After several years of relatively little enforcement\, FDA has recently been flexing its muscles in the promotion area. The Office of Prescription Drug Promotion (OPDP) in particular has issued several notable warning and untitled letters in the past year\, representing an increased volume in enforcement and increased scrutiny of efficacy claims. This includes more rigorous assessment of information “consistent with” FDA-required labeling (CFL) and enforcement of new expectations for presentation of quantitative efficacy information. Tune in to this overview session for an efficient rundown of what this means for drug\, biological product\, and device manufacturers in terms of key watchouts and practical approaches to risk mitigation. \nRSVP here.\n \n1:00 p.m. – 2:00 p.m. ET \nCLE credit will be offered for this webinar.\nSidley Austin LLP is an accredited MCLE provider in IL\, NY\, and CA. Credit is available for CT\, NJ\, TX\, and VA upon request.
URL:https://goodlifesci.sidley.com/event/fdas-new-wave-of-promotion-enforcement-what-you-need-to-know-now/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240904
DTEND;VALUE=DATE:20240905
DTSTAMP:20260403T123425
CREATED:20240522T164830Z
LAST-MODIFIED:20240522T164830Z
UID:1944-1725408000-1725494399@goodlifesci.sidley.com
SUMMARY:Swiss MedTech 2024: Harnessing Market Dynamics for Profitability
DESCRIPTION:Join Sidley\, ISS AG\, and Swiss Medtech in Biel for an afternoon of practical tips and interactive discussions on current issues\, including: \n\nESG and its development in the EU\nSeizing the opportunities of Artificial Intelligence\nHealth data and clinical trials\n\n \n2:00 p.m. – 6:30 p.m. CET\nFollowed by a networking drinks reception \nRSVP here. \nIndustry speakers\, regulators\, scientific experts\, and counsel will share tips and best practices for the challenges and opportunities that lie ahead for Swiss MedTech. \nWHO SHOULD ATTEND?\nExecutives\, investors\, in-house counsel\, and regulatory managers interested in and/or facing regulatory issues in Switzerland. \nFor more information\, please contact Dafne Forni Zervoudaki at +32 2 504 6202 or at dafne.fornizervoudaki@sidley.com.
URL:https://goodlifesci.sidley.com/event/swiss-medtech-2024-harnessing-market-dynamics-for-profitability/
LOCATION:Farelhaus\, Oberer Quai 12\, 2503 Biel\, Switzerland\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240909
DTEND;VALUE=DATE:20240914
DTSTAMP:20260403T123425
CREATED:20240306T210249Z
LAST-MODIFIED:20240320T151628Z
UID:1835-1725840000-1726271999@goodlifesci.sidley.com
SUMMARY:Data Integrity and Governance Workshop
DESCRIPTION:Live Oak Workshops\, in collaboration with Sidley Austin\, are designed to equip you with the knowledge and critical thinking strategies that lead to success in the advancement of your GXP career. As worldwide regulatory expectations in the world of data integrity and data governance change\, our workshops prepare you with the skills necessary to interpret regulations\, guidance\, and regulatory action into simple approaches for managing your everyday GXP responsibilities with the efficiency needed to thrive. \nMonday\, September 9\, 2024 – Tuesday\, September 10\, 2024 | Ahmedabad\, India\nThursday\, September 12\, 2024 – Friday\, September 13\, 2024 | Hyderabad\, India \nSign up now to join us as we discuss\, debate\, question\, and tackle interesting regulatory case studies in the world of data integrity and data governance. \nWe are excited to now offer this worship in both Ahmedabad and Hyderabad this October. Click here to see the full two-day agenda. \nInstructors include former FDA India Office alums: \nPeter Baker\, President\, Live Oak\nFormer FDA Investigator\nPeter Baker is a GXP consultant focused on improving the quality of medicines by providing training and consulting services to organizations looking to improve the quality of their data integrity assurance strategy. Pete is a former FDA investigator whose Agency leadership included serving as Assistant Country Director (Drugs) in New Delhi\, where he performed high risk cGMP inspections of human drug manufacturers throughout India and the surrounding region\, conducted a variety of training and development exercises for manufacturers and foreign regulators\, performed joint GMP manufacturing inspections with a variety of foreign regulatory bodies\, and conducted joint investigations alongside local and regional investigation teams to facilitate harmonized regulatory actions. In 2013\, he was recognized as FDA Investigator of the year due to a significant number of FDA regulatory actions taken in India\, including product recalls and import bans based on inspections where breaches in data integrity were uncovered which affected a wide variety of products in US distribution. \nJay Jariwala\, Senior Director\, Regulatory Compliance\, Sidley\nFormer FDA Regulator\nFor over 13 years\, Jay served as an FDA regulator and leader at multiple FDA centers\, including CDER\, the Center for Devices and Radiological Health (CDRH)\, and the Office of the Commissioner\, applying the agency’s laws\, regulations\, guidance\, and other technical and administrative policies on drugs\, medical devices\, and combination products to policy development\, facility inspections\, compliance\, enforcement\, and approval processes. His FDA leadership experience includes serving as assistant country director (Drugs) and supervisory Consumer Safety officer in the agency’s India Office in New Delhi\, where he managed a team of investigators for all facility inspections conducted by the India Office and compliance follow-up. In addition to his responsibilities for resource planning and operational oversight for violative establishment inspection assessments and resulting regulatory actions\, Jay trained FDA investigators on current good manufacturing practice (CGMP) requirements — particularly data integrity and quality investigations. \nDan Roberts\, Senior Director\, Regulatory Compliance\, Sidley\nFormer FDA Investigator\nDan Roberts evaluates and assesses pharmaceutical quality systems and focuses on detecting and remediating data integrity concerns and evaluating compliant automated manufacturing processes and related computerized systems. He provides guidance and assists clients in responding to FDA-483 observations\, corresponding with regulatory agencies\, and conducting mock FDA facility audits. Dan has over 20 years of government regulatory and pharmaceutical/biopharmaceutical industry experience. He was an FDA investigator for eight years\, including two years as the primary point of contact for conducting pharmaceutical inspections at the FDA India office located at the U.S. Embassy in New Delhi. He was also the first lead investigator for the first biosimilar inspection conducted by the FDA in India. \nJim Johnson\, Partner\, Sidley\nFormer FDA Associate Chief Counsel\nJim Johnson guides life sciences companies through complex FDA compliance and enforcement matters\, including inspections\, current good manufacturing practices (GMP) requirements\, data integrity responsibilities\, product quality issues\, pharmacovigilance obligations\, and enforcement actions. Jim previously served as Associate Chief Counsel for Enforcement in the FDA’s Office of the Chief Counsel\, where he handled GMP enforcement and provided legal counsel on a range of inspectional and compliance issues to agency components\, particularly the FDA’s Office of Regulatory Affairs (ORA) and Center for Drug Evaluation and Research’s (CDER) Office of Compliance. Jim uses his extensive agency and private practice experience to assist pharmaceutical and biotechnology companies worldwide\, regularly conducting GMP assessments and investigations\, resolving warning letters and import alerts\, and appearing in front of the FDA on behalf of companies to resolve enforcement actions. \nDiscounts and Additional Information: \n\nContracts info@liveoakqa.com for groups of five or larger and receive a 10% discount code for checkout\nTea Breaks and lunch are included in the workshop.
URL:https://goodlifesci.sidley.com/event/data-integrity-and-governance-workshop/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240924
DTEND;VALUE=DATE:20240925
DTSTAMP:20260403T123425
CREATED:20240227T171412Z
LAST-MODIFIED:20240731T191635Z
UID:1817-1727136000-1727222399@goodlifesci.sidley.com
SUMMARY:Sidley Healthcare Investment Conference 2024
DESCRIPTION:Deal and investment activity remains critical to the success of life sciences and healthcare innovation. \nRSVP Here \n \n\n\n\n\n\n\n\nSidley once again brings together senior pharma\, biotech\, healthcare\, private equity\, and venture capital executives to share their perspectives on critical issues\, trends\, and opportunities. \nJoin Sidley and industry leaders from across the globe\, including from AstraZeneca\, BioCentury\, Compass Pathways\, Financial Times\, Flagship Pioneering\, IQVIA\, J.P. Morgan\, LetterOne Health\, Mestag Therapeutics\, Morgan Stanley\, Novartis\, Onex\, Permira\, Perspectum\, Rothschild & Co.\, Sofinnova Partners\, Syncona\, SV Health Investors\, and Teva for this in-person\, all-day event. Virtual attendance is available to those outside the UK. \nView the agenda here.\nView confirmed speakers here. \nPanels will include: \n\nPrivate Equity – What is the outlook for PE investment activity across Healthcare and Life Sciences? Which domains will be the “winners”?\n\nArtificial Intelligence – To what extent\, and where\, does AI represent an investment opportunity across Healthcare and Life Sciences?\n\nFireside Chat – “A Life in Pharma and Pivoting to Innovation”- A conversation with Richard Francis\, President and CEO\, Teva.\n\nA View From the Banks – Opinions\, insights\, and predictions on the market from a group of leading global healthcare dealmakers.\n\nPharma Business Development – Senior BD and biotech figures debate the M&A\, licensing\, and collaboration climate. Which therapeutic areas and geographies are garnering the most attention?\n\nVenture/Growth Capital – How are global funds investing in a more muted market? How do investees stand out? Views from leading global life sciences investors.\n\nPlease note\, due to space limitation for this event\, registrations will be reviewed and confirmed by email in due course. We strongly encourage in-person attendance and remote participation will be available to those based outside of the UK. \nFor more information or questions\, please contact lnevents@sidley.com. \nSIDLEY HEALTHCARE INVESTMENT CONFERENCE 2023 HIGHLIGHTS \n\nView the 2023 agenda\nSidley Healthcare Investment Conference 2023 Highlights Video\nA Life Well Invented: A Discussion Between Moderna Co-Founder and Chairman Noubar Afeyan and Sidley’s Robert Darwin
URL:https://goodlifesci.sidley.com/event/sidley-healthcare-investment-conference-2024/
LOCATION:The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, UK\, The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20241022T173000
DTEND;TZID=Europe/Zurich:20241022T210000
DTSTAMP:20260403T123425
CREATED:20240828T152816Z
LAST-MODIFIED:20241010T154919Z
UID:2005-1729618200-1729630800@goodlifesci.sidley.com
SUMMARY:Combination Therapies – EU Regulatory and Competition Law Headwinds and Strategies
DESCRIPTION:Join us in Basel for our next Women’s Life Sciences Network event. The panel will discuss key considerations related to authority expectations as well as challenges\, and potential strategies for EU regulatory and competition law compliance for combination therapies. \n \n\n\nRSVP here. \n\n\nSpeakers are: \n\nDr. Sandra Zaugg Kunz\, Head Regulatory Assessment Deputy Head of Medicinal Product Authorisation and Vigilance\, Swissmedic\nElisabeth Leimbacher\, Global Legal Lead\, Marketing and Commercial Excellence\, Takeda\nCeline Fang\, Senior Antitrust Counsel\, Novartis\n\nThe discussion will be moderated by Josefine Sommer and Anne Robert\, Partner\, Sidley. \nAGENDA \n5:30 p.m. – Arrival and registration\n6:00 p.m. – Panel discussion and Q&A\n7:30 p.m. – Networking and apéro riche \nFor more information\, please contact gvaevents@sidley.com.\nClick here to join the Women’s Life Sciences Network LinkedIn Group.\nFor more information about previous editions\, please click here.
URL:https://goodlifesci.sidley.com/event/combination-therapies-eu-regulatory-and-competition-law-headwinds-and-strategies/
LOCATION:Memox\, Peter-Merian Strasse 80\, Basel\, 4052\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20241114T140000
DTEND;TZID=Europe/Zurich:20241114T183000
DTSTAMP:20260403T123425
CREATED:20240923T150106Z
LAST-MODIFIED:20240923T150308Z
UID:2037-1731592800-1731609000@goodlifesci.sidley.com
SUMMARY:Good Manufacturing Practice 2024Swiss/FDA Mutual Recognition Agreement – State of Play
DESCRIPTION:Join us in Basel\, where Sidley and thought leaders will be discussing the FDA and Swissmedic Mutual Recognition Agreement on Good Manufacturing Practices for pharmaceutical products. This agreement aims to streamline regulatory processes and enhance cooperation between the two countries by recognizing each other’s GMP inspections\, thereby reducing the need for duplicative inspections. \n \nRSVP here. \nWe will discuss early experiences with the new framework — both positive outcomes and challenges — highlighting valuable lessons learned and exploring potential for future developments. \nTopics will include: \n\nFDA/Swiss Mutual Recognition Agreement\nAI and Good Manufacturing Practice\nEU’s New Revised Annex 1\n\nFeatured speakers: \n\nChristian Schärer\, Head of Inspectorate\, Swissmedic\, (keynote speaker)\nOliver Schläfli\, Senior Vice President Global Quality\, Lonza\nJay Jariwala\, Senior Director Regulatory Compliance\, Sidley\nJames Johnson\, Partner\, Sidley\nEva von Mühlenen\, Senior Advisor\, Sidley\n\nWHO SHOULD ATTEND? \nExecutives\, in-house counsel\, quality and compliance managers and officers interested in and/or facing GMP compliance and quality management challenges in Switzerland. \nFor more information or questions\, please contact gvaevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/good-manufacturing-practice-2024swiss-fda-mutual-recognition-agreement-state-of-play/
LOCATION:Memox\, Peter-Merian Strasse 80\, Basel\, 4052\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20250305T130000
DTEND;TZID=America/Los_Angeles:20250305T163000
DTSTAMP:20260403T123425
CREATED:20250124T223249Z
LAST-MODIFIED:20250228T223755Z
UID:2155-1741179600-1741192200@goodlifesci.sidley.com
SUMMARY:Regulatory Know-How for Growth-Stage Life Sciences Innovators
DESCRIPTION:Please join Sidley’s Global Life Sciences team to lean into key early-stage and emerging growth regulatory issues\, and how to tackle them. \n \nIf have questions or are interested in attending\, please contact laevents@sidley.com. \nSessions will focus on: \n\nAll phases of clinical research and development\nPress releases and disclosures\nRegulatory wisdom from experienced emerging growth General Counsels\n\nConnect with industry peers and investors during networking breaks and a post-program cocktail hour. \nThis program is designed for legal professionals and executives to provide a foundation in FDA\, healthcare\, and securities issues arising in development stage companies. \nFeatured Speakers \n\nHimani Bhalla\, Senior Managing Director\, Chief Investment Officer\, and Co-Founder\, Symbiotic Capital\nGreg Bowman\, Senior Director\, Leasing\, Breakthrough Properties\nMichael Brown\, Executive Vice President and Chief\, Legal Officer\, DexCom\, Inc.\nAneta Ferguson\, Senior Vice President and General Counsel\, Adverum Biotechnologies\nMichael Mueller\, General Counsel\, Sidewinder Therapeutics\, Inc.\n\nSidley Speakers \n\nTorey Cope\, Food\, Drug\, and Medical Device Regulatory\nMeenakshi Datta\, Healthcare: Drug and Medical Device Regulatory\nCarlton Fleming\, Capital Markets\nCindy Lovering\, Global Finance\nJames Lu\, Emerging Companies and Venture Capital\nJon Olsen\, M&A\, Emerging Companies and Venture Capital\nAdam Welland\, Technology and Life Sciences Transactions\nSharon Flanagan\, M&A\, Capital Markets\, Corporate Governance\n\nAgenda \n1:00 p.m.: Registration\n1:30 – 4:30 p.m.: \n\nClinical Research Challenges and Opportunities\nKey Considerations for Press Releases and SEC Disclosures\nFireside Chat: The Importance of Regulatory Strategy and Compliance from Seasoned Emerging Growth GCs\n\n4:30 – 6:30 p.m.: Cocktail Reception \nCLE credit for this program is pending.
URL:https://goodlifesci.sidley.com/event/regulatory-know-how-for-growth-stage-life-sciences-innovators/
LOCATION:Torrey Heights\, 11208 El Camino Real\, San Diego\, CA\, 92130\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250519
DTEND;VALUE=DATE:20250520
DTSTAMP:20260403T123425
CREATED:20250212T184003Z
LAST-MODIFIED:20250401T204125Z
UID:2163-1747612800-1747699199@goodlifesci.sidley.com
SUMMARY:Boston Life Sciences Roundtable
DESCRIPTION:Join Sidley’s Life Sciences team for an afternoon of thought-provoking and engaging discussions touching on the latest trends and hot topics including the new administration\, new technologies\, the investment landscape\, and more. \n \n\n\nFor more information\, contact bosevents@sidley.com. \n\n\nThis year’s fifth annual event will be held in the stunning Institute of Contemporary Art/Boston lobby\, followed by a reception on the picturesque harbor front plaza. \nPlease see below for details on our newly announced panels and panelists. \nWHO SHOULD ATTEND\nExecutives\, Investors\, General Counsel\, and Company Counsel \nAGENDA\nRegistration: 1:30 p.m. ET\nProgram: 2:00 p.m. ET\nReception: 5:00 p.m. – 6:30 p.m. ET \nFEATURED PANEL TOPICS \nThe New Administration\, Trade Wars\, and GC Strategies For Managing A Changing Environment\nAs the New Administration brings personnel and policy changes to HHS and FDA\, and trade wars add new considerations for product development and manufacturing\, we reflect on key developments and strategies GCs use to successfully manage the opportunities and risks in a changing environment. \n– Lana Gladstein\, General Counsel\, Seaport Therapeutics \n– Jose Truzman\, General Counsel – U.S.\, Intercept Pharmaceuticals\, Inc. \n– Aaron Applebaum\, Counsel\, Global Arbitration\, Trade and Advocacy \n– Jackson Garvey\, Partner\, Restructuring & Liability Management \n– Becky Wood\, Partner\, Global Co-leader\, Food\, Drug and Medical Device and Former Chief Counsel\, FDA \nNew Product Development Pathways for Success\nThis panel will discuss key areas of focus during product development to set companies up for success\, including the use of artificial intelligence (AI)\, pre-approval compliance considerations\, and pricing strategies. \n– Meena Datta\, Partner\, Global Co-leader\, Healthcare\n– Deeona Gaskin\, Partner\, Food\, Drug and Medical Device and Former Associate Chief Counsel for Enforcement\, FDA \nNavigating Life Sciences Transactions in a Dynamic Economic Landscape\nThis panel will discuss the evolving landscape of life sciences transactions\, including emerging trends in the current investment climate. \n– Shaan Gandhi\, Head of Strategic Partnerships\, Pfizer Ignite \n– Paresh Kumar\, Vice President\, Biotech Private Equity\, Ally Bridge Group \n– Jason Tse\, Vice President Corporate Development\, McKesson \n– Chris York\, Vice President\, General Counsel & Chief of Staff\, Orchard Therapeutics \n– Mat Eapen\, Partner\, Investment Funds \nKEYNOTE ADDRESS\n“Get Your Mindset Right”: Thriving in Change\nA Conversation with Kirk Taylor\, MD on Navigating Changing Times \nKirk Taylor\, MD\nPresident & CEO\nMassachusetts Life Sciences Center \nKirk Taylor\, MD is a global pharmaceutical executive with expertise in Phase II – IV drug development\, including CNS\, oncology and rare disease. As Chief Medical Officer\, Chief Strategy Officer and SVP Medical Affairs\, he has restructured organizations\, created strategic operating plans\, and shaped corporate culture. His entrepreneurial acumen assisted in leading biotech start-up companies to successful IPOs and multiple funding rounds. He is people-first focused\, leading teams with respect and innovation. In recognition of his positive impact\, he was awarded the 2023 PharmaVoice 100 Executives Award. \nDr. Taylor received his Bachelor of Arts from Harvard College and studied piano at the Longy School of Music in Cambridge. He completed his Doctor of Medicine from the State University of New York\, Downstate\, his neurology residency at Einstein College of Medicine\, and a post-doc at UCSF.
URL:https://goodlifesci.sidley.com/event/boston-life-sciences-roundtable-4/
LOCATION:The Institute of Contemporary Art/Boston\, 25 Harbor Shore Drive\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250520T173000
DTEND;TZID=America/Chicago:20250520T200000
DTSTAMP:20260403T123425
CREATED:20250304T201351Z
LAST-MODIFIED:20250324T203422Z
UID:2183-1747762200-1747771200@goodlifesci.sidley.com
SUMMARY:Women’s Life Sciences Network Event – Brussels
DESCRIPTION:Join us in Brussels for our next Women’s Life Sciences Network event on the occasion of the EU Pharmaceutical Law Forum. The event will feature a moderated discussion on topical issues of pharmaceutical legislation and policy. \n \nRSVP here. \nSPEAKERS \n\nRainer Becker\, Director\, DG SANTE\, European Commission\nVictoria Kitcatt\, Vice President and Assistant General Counsel\, Head of EU/International Regulatory Law\, Pfizer\nLaetitia Szaller\, General Counsel\, Head of Compliance and ESG\, Egetis Therapeutics\n\nA Q&A session will follow the discussion. \nAGENDA \n5:30 p.m. – Welcome\n6:00 p.m. – Panel discussion\n7:00 p.m. – Networking reception and canapés \nAll are invited to attend WLSN events.
URL:https://goodlifesci.sidley.com/event/womens-life-sciences-network-event-brussels/
LOCATION:Comet\, Place Stephanie 50\, Brussels\, 1050\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20250603T154500
DTEND;TZID=Europe/Zurich:20250603T170000
DTSTAMP:20260403T123425
CREATED:20250505T155312Z
LAST-MODIFIED:20250505T155329Z
UID:2252-1748965500-1748970000@goodlifesci.sidley.com
SUMMARY:Good Manufacturing Practice 2025AI in Manufacturing
DESCRIPTION:Join us for an insightful and practical webinar on “Navigating AI Adoption in GMP-Regulated Areas While Staying Compliant.” \n \nWebinar | RSVP here. \nKey Insights: \n\nAI in Pharma Production: Explore how AI is revolutionizing pharmaceutical production through process automation\, real-time quality control\, predictive maintenance\, and AI-driven batch release decisions.\nRegulatory Perspectives: Gain insights into how regulators in the U.S. and the EU are approaching AI in GMP-compliant manufacturing\, focusing on validation\, risk management\, and compliance expectations.\nBroader Frameworks: Understand how AI adoption fits into broader regulatory frameworks like the EU AI Act.\n\nFeatured Speakers: \n\nGert Thurau\, Lead Technology Innovation Manufacturing\, CMC Regulatory Policy\, Roche\nJames Johnson\, Partner\, Sidley\nDaniel J. Roberts\, Senior Director\, Regulatory Compliance\, Sidley\nEva von Mühlenen\, Senior Advisor\, Sidley\n\nWhy Attend? \nThis session will provide a real-world discussion on how companies can effectively integrate AI into their operations while adhering to Good Manufacturing Practice (GMP) regulations. \nLearn from industry and regulatory thought leaders about the latest trends and best practices in AI adoption within GMP-regulated environments. \nWho Should Attend? \nExecutives\, in-house counsel\, quality and compliance managers and officers interested in and/or facing GMP compliance and quality management challenges in Switzerland. \n\nFor more information or questions\, please contact gvaevents@sidley.com. \nNothing in this program may be quoted or used in any manner without the express written consent of Sidley Austin LLP. The views expressed in this program are the views of the participants\, and not necessarily those of the firm. This program is for informational purposes only and should not be considered legal advice or creating an attorney-client relationship.
URL:https://goodlifesci.sidley.com/event/good-manufacturing-practice-2025ai-in-manufacturing/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250723T130000
DTEND;TZID=America/Chicago:20250723T163000
DTSTAMP:20260403T123425
CREATED:20250611T160543Z
LAST-MODIFIED:20250625T215158Z
UID:2345-1753275600-1753288200@goodlifesci.sidley.com
SUMMARY:Bay Area Lifesciences Roundtable Navigating Uncertainty and Charting a New Course
DESCRIPTION:Join industry leaders\, investors\, and seasoned regulatory counsel for an exclusive event focused on thriving during times of change in the life sciences sector. Through dynamic panel discussions\, we’ll explore the latest trends in regulation\, financing\, market dynamics\, and federal health policy\, all with a focus on how companies can continue to realize the transformative impact of new therapies and technologies. Don’t miss this opportunity to connect\, learn\, and chart a new course for long-term business success. \nRSVP here. \nAGENDA\nRegistration | 1:00 p.m.\nProgram | 1:30 p.m.\nReception 4:30 p.m. \nWho may be interested in attending: Executives\, Directors\, Investors\, and In-House Counsel \nFEATURED PANELS \nRegulatory Realities – Proactive Strategies in a Shifting Landscape \nExplore how companies are developing new strategies to respond to the latest developments at HHS\, FDA\, and CMS\, including major shifts in FDA leadership\, staffing\, and policy priorities\, potential impacts on regulatory timelines and new product approvals\, and new proposals related to drug pricing and reimbursement. Hear from industry insiders on how to engage effectively with regulators and adapt to new expectations in an era of uncertainty. \nSPEAKERS\n \n\nAnthony Davies\, Ph.D.\, Founder & CEO\, Dark Horse Consulting\nHae-Won Min Liao\, Vice President\, U.S. Legal Business Partner\, Gilead Sciences\nEmily Marden\, Senior Counsel\, Sidley\nCatherine Starks\, Partner\, Sidley\n\nAdditional panelists to be announced \nFinancing the Future – Paths to Growth and Liquidity \nDiscover how investment opportunities are evolving\, with a focus on financing and liquidity options including debt\, royalty financing\, mergers\, and other strategic transactions. Leading advisors and investors will share their experience\, including how shifting geopolitical and regulatory factors are shaping deals\, and what it takes to secure funding and achieve liquidity in today’s market. \nSPEAKERS\n \n\nRyuk Byun\, Managing Director\, Morgan Stanley\nHutch Corbett\, Managing Partner\, Armentum Partners\nCarlton Fleming\, Partner\, Sidley\nFrank Rahmani\, Partner\, Sidley\n\nAdditional panelists to be announced \nThe GLP-1 Effect – Disruption\, Demand\, and What’s Next for Biotech \n Using GLP-1 as a case study\, dive into the latest trends in product development\, pricing and reimbursement\, market dynamics\, and federal health policy. This panel will examine issues that have arisen for the paradigm-shifting GLP-1/GIP/Gcg product category\, to reveal for the future of innovation across the entire life sciences industry. \nSPEAKERS \n\nScott Akamine\, Chief Legal Officer\, Kailera Therapeutics\nMichael Hulka\, Senior Vice President and Deputy General Counsel\, Eli Lilly and Company\nTorrey Cope\, Partner\, Sidley\n\nAdditional panelists to be announced \nCLE credit for this program is pending.\n\nFor more information\, contact sfevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/bay-area-lifesciences-roundtable-navigating-uncertainty-and-charting-a-new-course/
LOCATION:SFMOMA\, 147 Minna St. Floor 5\, San Francisco\, CA\, 94103\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20250902T140000
DTEND;TZID=Europe/Zurich:20250902T183000
DTSTAMP:20260403T123425
CREATED:20250425T150936Z
LAST-MODIFIED:20250429T155305Z
UID:2246-1756821600-1756837800@goodlifesci.sidley.com
SUMMARY:Swiss MedTech 2025Staying Competitive in a Shifting Regulatory Landscape
DESCRIPTION:The Swiss MedTech industry stands at a critical crossroads: navigating rapid regulatory evolution\, geopolitical shifts\, and emerging technologies. \n \n\n\nRSVP here. \nFor more information\, please contact Geneva Events. \n\n\nJoin us in Bern for an interactive afternoon featuring regulators\, industry leaders\, legal professionals\, and scientific advisors who will share practical insights\, best practices\, and strategic foresight. \nKey highlights on the agenda include: \n\nRegulatory Realities and Priorities\nHow Swiss MedTech Stays Competitive Amid Regulatory Shifts\nGlobal Trade and Politics\nU.S. Policy in 2025 – Implications for Swiss Market Access and Trade Strategy\nCorporate Responsibility\nFrom ESG to the Omnibus Act – What Swiss MedTech Must Now Comply With\nNew Pathway of Regulating Artificial Intelligence in Switzerland\nCompetitive Edge or Compliance Hurdle?
URL:https://goodlifesci.sidley.com/event/swiss-medtech-2025staying-competitive-in-a-shifting-regulatory-landscape/
LOCATION:Casino Bern\, Casinoplatz 1\, 3011\, Bern\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Singapore:20250903T093000
DTEND;TZID=Asia/Singapore:20250903T130000
DTSTAMP:20260403T123425
CREATED:20250828T181249Z
LAST-MODIFIED:20250828T181450Z
UID:2427-1756891800-1756904400@goodlifesci.sidley.com
SUMMARY:Singapore Life Sciences Roundtable
DESCRIPTION:This intimate\, industry-focused session will bring together legal and compliance professionals from multinational pharmaceutical\, medtech\, and biotech companies to explore how recent global developments are reshaping the regulatory and transactional landscape across Asia-Pacific. \n \n\n\nRSVP here. \n\n\nTopics include: \n– The New DOJ White Collar Enforcement Playbook\nWhat it means for APAC operations and compliance functions \n– The New U.S. Administration and the FDA\nTaking stock of paradigm-shifting developments in drug and device regulation \n– Life Sciences Transactions in APAC\nNavigating deal risks\, regulatory scrutiny\, and cross-border trends \nPROGRAM\nRegistration and Refreshments: 9:30 a.m. – 10:00 a.m. SGT\nSidley Presentation and Roundtable Dialogue: 10:00 a.m. – 12:00 p.m. SGT\nNetworking Lunch: 12:00 p.m. – 1:00 p.m. SGT \nFor questions or more information\, please contact asiaevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/2427/
LOCATION:Sidley\, 1501 K Street\, NW Washington\, D.C.\, 20005\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250915T180000
DTEND;TZID=America/Chicago:20250915T200000
DTSTAMP:20260403T123425
CREATED:20250812T223817Z
LAST-MODIFIED:20250812T223841Z
UID:2392-1757959200-1757966400@goodlifesci.sidley.com
SUMMARY:Sidley’s Medicaid Drug Rebate Program Summit Cocktail Reception
DESCRIPTION:Please join members of Sidley’s Drug Pricing Team for appetizers and cocktails – right near Chicago’s iconic Bean in Millennium Park – following Day 1 of the MDRP Summit. \n \n\n\nRSVP here \n\n\nWe look forward to connecting with you! \nFor questions\, please contact chevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/2392/
LOCATION:Avli on the Park\, 180 N Field Blvd\, Chicago\, IL\, 60601
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250930
DTEND;VALUE=DATE:20251001
DTSTAMP:20260403T123425
CREATED:20250218T171058Z
LAST-MODIFIED:20250218T205917Z
UID:2169-1759190400-1759276799@goodlifesci.sidley.com
SUMMARY:Sidley Healthcare Investment Conference 2025
DESCRIPTION:With deal and investment activity remaining critical to the success of the life sciences and healthcare industry\, Sidley is bringing together senior pharma\, biotech\, healthcare\, private equity\, and venture capital leads to provide their insights on key topics\, trends\, and opportunities. \n \n\n\nRSVP here. \n\n\nJoin Sidley and industry leaders from across the globe for this in-person\, one-day event in London\, with the option to stream and network virtually from outside the UK. \nWe look forward to incisive content\, robust discussion\, and valuable networking during a day of looking at the continued combination of innovation and capital driving positive patient outcomes and investment returns. \nView the Sidley Healthcare Investment Conference 2024 highlights. 
URL:https://goodlifesci.sidley.com/event/sidley-healthcare-conference-2025/
LOCATION:The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, UK\, The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20251021T173000
DTEND;TZID=Europe/Zurich:20251021T210000
DTSTAMP:20260403T123425
CREATED:20250630T164241Z
LAST-MODIFIED:20250630T164357Z
UID:2357-1761067800-1761080400@goodlifesci.sidley.com
SUMMARY:Women's Life Sciences NetworkGeopolitical and Trade Uncertainties: Strategies for the Life Sciences Industry
DESCRIPTION:Join us in Basel for our next Women’s Life Sciences Network event\, which will feature a panel discussion with leading life science industry representatives about the challenges and opportunities arising from increasingly volatile and fragmented international trade dynamics. \n \n\n\nRSVP here. \nThe panel will share insights and considerations on the impact on life science companies’ operations and compliance efforts of\, among others\, new tariffs\, retaliation measures\, and other recent trade restrictions implemented in an evolving geopolitical context where countries seek to rebalance trade relations. A Q&A session will follow the moderated discussion. \n\n\nAll are invited to attend WLSN events. \nAGENDA \n5:30 p.m. – Arrival and registration\n6:00 p.m. – Panel discussion and Q&A\n7:30 p.m. – Networking and apéro riche \nFor more information\, please contact brevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/womens-life-sciences-networkgeopolitical-and-trade-uncertainties-strategies-for-the-life-sciences-industry/
LOCATION:Memox\, Peter-Merian Strasse 80\, Basel\, 4052\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260112T113000
DTEND;TZID=America/Los_Angeles:20260112T143000
DTSTAMP:20260403T123425
CREATED:20251106T172447Z
LAST-MODIFIED:20251113T221810Z
UID:2566-1768217400-1768228200@goodlifesci.sidley.com
SUMMARY:Biotech Dealmaking - Regulatory Considerations for the Next Wave of Development-Stage Transactions - Program and Lunch
DESCRIPTION:Join members of Sidley’s Global Life Sciences team for a lunchtime CLE-accredited program during the JPM Healthcare Conference discussing the latest regulatory trends impacting the next wave of development-stage transactions.\n \nLed by Meena Datta\, global co-leader of Sidley’s Healthcare practice; Torrey Cope\, partner in Sidley’s Food Drug and Medical Device (FDMD) practice; and Sally Wagner Partin\, partner in Sidley’s M&A practice\, this session provides keen insights on the considerations driving recent biotech dealmaking. 1 hour CLE credit available. \nFor questions\, please contact sfevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/biotech-dealmaking-regulatory-considerations-for-the-next-wave-of-development-stage-transactions-program-and-lunch/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260112T133000
DTEND;TZID=America/Los_Angeles:20260112T173000
DTSTAMP:20260403T123425
CREATED:20251120T220607Z
LAST-MODIFIED:20251211T230935Z
UID:2582-1768224600-1768239000@goodlifesci.sidley.com
SUMMARY:Connecting Clusters of Excellence: Europe as Your Gateway to Global Success
DESCRIPTION:Join Sidley\, Biovia\, Health Campus Limburg DC\, and others for an engaging afternoon exploring collaborative growth opportunities across the global life sciences landscape. \n \nRSVP here. \nThe event will feature two dynamic panel discussions\, with the latter being moderated by Sidley’s Becky Wood\, global co-leader of Sidley’s FDA practice and former Chief Counsel at FDA. \nPanel 1: Europe Recharged: Innovation Thrives Here. We Are Ready for the Global Stage. \nEurope’s biotech and healthtech ecosystems are accelerating. With strong public-private partnerships\, world-class research\, and coordinated investment strategies\, Europe is no longer catching up\, it’s setting the pace. Discover how clusters across the continent are shaping global markets through collaboration and scale. \nPanel 2: Redefining Women’s Health: Europe and the U.S. Unite to Power Innovation\, Investment\, and Impact. \nA new wave of investors and innovators is turning women’s health into one of the fastest-growing markets in healthcare. How can we ensure women’s health is not just a “hot topic\,” but an enduring pillar of innovation and research? This panel brings together U.S. and European leaders driving science\, technology\, and capital toward an overdue revolution in women’s health\, from overlooked needs to global opportunities. \nThis gathering brings together leaders\, innovators\, and ecosystem builders to spark meaningful dialogue and foster new pathways for international collaboration. \nPlease note that delegate contact details may be passed between Sidley Austin LLP\, Biovia\, and Health Campus Limburg DC for the purposes of organizing and administering these events\, and for contacting you about these events. The organizers are using third party websites\, not controlled by Sidley\, and your personal information will be processed in accordance with the Eventbrite Privacy Policy. For information on Sidley’s use of your personal information please refer to our Privacy Policy and for questions about these events please contact sfevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/connecting-clusters-of-excellence-europe-as-your-gateway-to-global-success/
LOCATION:The Town Hall\, 555 California Street\, San Francisco\, CA\, 94104\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260128T093000
DTEND;TZID=America/New_York:20260128T163000
DTSTAMP:20260403T123425
CREATED:20251001T204927Z
LAST-MODIFIED:20251203T215202Z
UID:2547-1769592600-1769617800@goodlifesci.sidley.com
SUMMARY:At the Table: Serving Up a Lively Discussion With the FDA and USDA
DESCRIPTION:Please join Sidley’s Food\, Drug\, and Medical Device team for a Meet the Regulators Roundtable which will include: Stephen A. Vaden\, USDA Deputy Secretary; Tyler Clarkson\, USDA General Counsel; Kyle Diamantas\, FDA Deputy Commissioner for Human Foods\, and Sean Keveney\, FDA Chief Counsel. \n \n\n\n\n\nFor registration information\, please contact dcevents@sidley.com. \n\n\n\n\nAgenda \nRegistration | 9:30 a.m. ET\nPanels | 10:00 a.m. – 12:10 p.m. ET\nLunch | 12:15 p.m. – 1:15 p.m. ET\nMeet the Regulators Roundtable | 1:30 p.m. – 3:00 p.m. ET\nCocktail Reception | 3:00 p.m. – 4:30 p.m. ET \nThe event will bring together industry leaders for a lively discussion on regulatory compliance\, enforcement actions\, litigation\, and related issues facing the food industry. \nPanel discussions prior to the Regulator Roundtable will include: \n– The Changing Landscape in Washington Food Regulation\n– Enforcement and Litigation – Risks\, Opportunities\, and Trends \nCLE credit is pending for this program. Sidley Austin LLP is an Approved Accredited Provider of CA\, IL\, and NY CLE credit.
URL:https://goodlifesci.sidley.com/event/at-the-table-serving-up-a-lively-discussion-with-the-fda-and-usda/
LOCATION:Sidley\, 1501 K Street\, NW Washington\, D.C.\, 20005\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260212T083000
DTEND;TZID=Europe/Brussels:20260212T170000
DTSTAMP:20260403T123425
CREATED:20251202T213607Z
LAST-MODIFIED:20251202T213607Z
UID:2591-1770885000-1770915600@goodlifesci.sidley.com
SUMMARY:Life Sciences College 2026
DESCRIPTION:Join EUCOPE and Sidley for the annual Life Sciences College (LSC) for an exclusive\, full-day forum on the future of life sciences in Europe. \n \nRSVP here. \nGet ready for a high-impact day of insight and connection at LSC\, where life sciences leaders gather to explore the legal\, regulatory\, and policy shifts shaping the industry. \nWhy Attend?\n \n– Connect with key decision-makers from the European Commission\, regulatory bodies\, industry\, and the investment community \n– Hear exclusive insights on legal\, policy\, and regulatory trends shaping the EU life sciences landscape \n– Join strategic discussions on emerging challenges and opportunities across the sector \n– Network with leaders from pharma\, biotech\, medtech\, and venture capital \nWho Should Attend \nIn-house counsel\, regulators\, and regulatory personnel.There is no registration fee to attend this event. \nFor more information\, contact brevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/life-sciences-college-2026/
LOCATION:Renaissance Brussels Hotel\, Rue du Parnasse 19\, Brussels\, 1000\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260519
DTEND;VALUE=DATE:20260522
DTSTAMP:20260403T123425
CREATED:20260223T171206Z
LAST-MODIFIED:20260223T171206Z
UID:2648-1779148800-1779407999@goodlifesci.sidley.com
SUMMARY:Sidley Sponsors the 2026 EU Pharma Law Forum
DESCRIPTION:Sidley is proud to sponsor and participate in the EU Pharma Law Forum\, the leading annual gathering of regulators\, in-house counsel\, policymakers\, and industry stakeholders shaping the future of European pharmaceutical law. \nView agenda here. \nSidley partner Anne Robert will be speaking on “How to Respond to Dawn Raids and Investigations.” Josefine Sommer will present on “Early Experiences from the HTA Regulation: Market Access Pricing and Reimbursement.” \nWe look forward to connecting with clients\, colleagues\, and industry leaders in Brussels to discuss the evolving legal landscape and the strategic considerations facing the pharmaceutical sector in 2026 and beyond.
URL:https://goodlifesci.sidley.com/event/sidley-sponsors-the-2026-eu-pharma-law-forum/
LOCATION:Steigenberger Icon Wiltcher’s\, Brussels
END:VEVENT
END:VCALENDAR